Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies

- Company to leverage expertise in mitochondrial biology to advance novel treatments for both rare and common diseases -

- Pretzel founded by leading academic experts in mitochondrial biology and backed by world-class investor syndicate -